Spero Therapeutics (SPRO) Current Assets (2016 - 2025)
Historic Current Assets for Spero Therapeutics (SPRO) over the last 10 years, with Q3 2025 value amounting to $52.3 million.
- Spero Therapeutics' Current Assets fell 6024.9% to $52.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.3 million, marking a year-over-year decrease of 6024.9%. This contributed to the annual value of $107.3 million for FY2024, which is 1823.97% down from last year.
- As of Q3 2025, Spero Therapeutics' Current Assets stood at $52.3 million, which was down 6024.9% from $59.4 million recorded in Q2 2025.
- Over the past 5 years, Spero Therapeutics' Current Assets peaked at $157.9 million during Q4 2021, and registered a low of $52.0 million during Q2 2022.
- Over the past 5 years, Spero Therapeutics' median Current Assets value was $107.3 million (recorded in 2024), while the average stood at $104.6 million.
- Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 9328.38% in 2023, then tumbled by 6024.9% in 2025.
- Quarter analysis of 5 years shows Spero Therapeutics' Current Assets stood at $157.9 million in 2021, then decreased by 28.06% to $113.6 million in 2022, then increased by 15.53% to $131.2 million in 2023, then decreased by 18.24% to $107.3 million in 2024, then crashed by 51.23% to $52.3 million in 2025.
- Its Current Assets was $52.3 million in Q3 2025, compared to $59.4 million in Q2 2025 and $74.7 million in Q1 2025.